Mark Samuels

Mark Samuels is a prominent figure in the healthcare industry, serving as the CEO of the British Generic Manufacturers Association.

He has a vast leadership experience in various sectors including government, NHS research, pharmaceuticals, diagnostics, medtech, and biotech.

Mark has excelled in roles such as Chief Executive Officer, General Management, and Alliance Management, showcasing expertise in areas like Transformational Change, Business Development, and Marketing.

He played a critical role in the establishment of the Medicines Discovery Catapult and secured significant funding for the organization.

Mark has been actively involved in clinical research and industry partnerships, contributing to the advancement of innovative treatments.

His contributions to the UK's Life Sciences sector have been substantial, as seen through his involvement in strategy development, stakeholder management, and advocacy for innovation.

Mark's educational background includes a PGDip from the University of Oxford and a BSc (Hons) from Queen Mary, University of London, reflecting his commitment to continuous learning and professional development.

Throughout his career, Mark has held key positions in organizations such as the University of Birmingham, Manchester Clinical Research Facility, and the Medicines Discovery Catapult, demonstrating his versatility and expertise.

His extensive experience spans from leading government organizations to working in the private sector, showcasing his adaptability and strategic acumen.

Mark Samuels' professional journey has been marked by success, with a focus on clinical research, medical technology, diagnostics, and strategic management in the life sciences industry.